A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures
Clinical trial NCT03325439 · TERMINATED
Trial details
- NCT number
- NCT03325439
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2020-09-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.